Get Instant Summarized Text (Gist) Blocking the chemokine receptor CCR1 can enhance the response of multiple myeloma cells to dexamethasone, a common treatment. High CCR1 levels are associated ...

"Anti-GPRC5D CAR T-cell salvage therapy induced a high response rate and might be a potential treatment option in patients with relapsed or refractory multiple myeloma who had pro ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all ...

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment responses in multiple myeloma patients by blocking a protein that plays a key ...